UCB (EBR:UCB) UCB Media Room - Transparency Notifications

Transparency directive : regulatory news

07/08/2019 20:01

https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W2= 7HkUdGSImvHQ6HnxeeiysVZrCZyCvoCjypIVyRozhYtKRQKYQL7a7-2BEWqaq3VuUWUfPDeyZS3= Kqd9-2BHkdKNsyFbAUPXmpSaKHQeW83-2F_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5Bwm= FRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsACjrdO= lflPThE-2FfjKrO2oE5hgz3F99bFs6ymkJAL5hjKbtWLrkB-2BYzNX0AOedNP42fCwgKj2KeSrj= -2FfHChuHRcYFO2ggA95Hs-2Bogz6Q3lXPwfpj8tAyOz-2BGhICPgSzklv9j3KI3mHxR9vUtX4r= 1APuOFkJ5ygJ2x-2FFzHBe21ccAE0UrohqSWt7VzcSolWHIBzO-2F4TpxaLO3jM5VBhWpwp60RC= 3QVzQ-2FYsSUH3n6DXEDn-2B9RaFXl1Yndd3sIqXwlBBw-3D ** Transparency notifications BlackRock, Inc. ------------------------------------------------------------ =C2=B7 Notifications referring to situation on 31 July, 1, 2 and 5 August 2= 019 =C2=B7 Threshold crossed: 5% =C2=B7 Latest holding: 5.16% Brussels (Belgium), 7 August 2019 =E2=80=93 20:00 (CEST) =E2=80=93 regulate= d information 1.=C2=A0 Summary of the notifications Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large = shareholdings, UCB=C2=A0SA/NV announces that it has received 4 transparency= notifications from BlackRock, Inc. (having its registered office at 55 Eas= t 52nd Street, New York, NY, 10055, U.S.A.), dated 1, 2, 5 and 6 August 201= 9 respectively. In the first notification, BlackRock, Inc., has notified that, following an= acquisition of UCB=C2=A0shares with voting rights and a disposal of equiva= lent financial instruments by its affiliates, its total holding in UCB SA/N= V has increased and has crossed the 5% threshold on 31 July 2019. On 31 July 2019, BlackRock, Inc. (taking into account the holding of its af= filiates) Inc. owned 9 581 467 UCB=C2=A0shares with voting rights (versus 9= 438 644 in its previous notification), representing 4.93% of the total num= ber of shares issued by the company (194 505 658) (versus 4.85% in its prev= ious notification), as well as 177 514 equivalent financial instruments (ve= rsus 186 998 in its previous notification) representing 0.09% of the total = number of shares issued by the company (versus 0,10% in its previous notifi= cation). In the second notification, BlackRock, Inc., has notified that, following a= n acquisition of UCB=C2=A0shares with voting rights by its affiliates, its = holding of UCB shares with voting rights has increased and has crossed the = 5% threshold on 1 August 2019. On 1 August 2019, BlackRock, Inc. (taking into account the holding of its a= ffiliates) owned 9 790 040 UCB=C2=A0shares with voting rights, representing= 5.03% of the total number of shares issued by the company, as well as 184 = 303 equivalent financial instruments, representing 0.09% of the total numbe= r of shares issued by the company. In the third notification, BlackRock, Inc., has notified that, following a = disposal of UCB=C2=A0shares with voting rights by its affiliates, its holdi= ng of UCB shares with voting rights has decreased and has crossed downwards= the 5% threshold on 2 August 2019. On 2 August 2019, BlackRock, Inc. (taking into account the holding of its a= ffiliates) owned 9 698 910 UCB=C2=A0shares with voting rights, representing= 4.99% of the total number of shares issued by the company, as well as 190 = 730 equivalent financial instruments, representing 0.10% of the total numbe= r of shares issued by the company. In the fourth notification, BlackRock, Inc., has notified that, following a= n acquisition of UCB=C2=A0shares with voting rights by its affiliates, its = holding of UCB shares with voting rights has increased and has crossed the = 5% threshold on 5 August 2019. On 5 August 2019, BlackRock, Inc. (taking into account the holding of its a= ffiliates) owned 9 830 066 UCB=C2=A0shares with voting rights, representing= 5.05% of the total number of shares issued by the company, as well as 199 = 838 equivalent financial instruments, representing 0.10% of the total numbe= r of shares issued by the company. 2.=C2=A0 Further information This press release and the detailed transparency notifications are availabl= e on UCB=C2=A0SA/NV=E2=80=99s website via the following link (https://u7061= 146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQB7X3kY45D7w88RKNKE= bAnX0k168L1blu4vXqw-2F8RdooEQ6SU3zroSdeAFOVg4KQLSg-3D-3D_-2B-2Ft0TnE1oEbVIW= S8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElH= Q9EZfLoWbvi8z1TsACjrdOlflPThE-2FfjKrO2oE5hgz3F99bFs6ymkJAL5hjKbtWLrkB-2BYzN= X0AOedNP42fCwgKj2KeSrj-2FfHChuHRcYFO2ggA95Hs-2Bogz6Q3lXPwW-2Fzeev82pUZidshC= 0BR5cIKUnkx7MB78Sp8LqRVm5NBaMe6XlK6MLAFpzNohAIiB3HSID9lg6tBSjK5HkTVh4bX5O5s= z0AUuCUCvV3aCMx8TH0ymUYwDn9KULLPPRRne20uZePpUrZBlGegTVYRDWk-3D . An updated overview of the UCB=C2=A0SA/NV large shareholdings will be avail= able on UCB=C2=A0SA/NV=E2=80=99s website via the following link (https://u7= 061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQB7X3kY45D7w88RK= NKEbAnX0k168L1blu4vXqw-2F8RdooEQ6SU3zroSdeAFOVg4KQLSg-3D-3D_-2B-2Ft0TnE1oEb= VIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTef= ElHQ9EZfLoWbvi8z1TsACjrdOlflPThE-2FfjKrO2oE5hgz3F99bFs6ymkJAL5hjKbtWLrkB-2B= YzNX0AOedNP42fCwgKj2KeSrj-2FfHChuHRcYFO2ggA95Hs-2Bogz6Q3lXPweYuc-2BiB5O-2Bs= wqFTBs-2FUDKV9cISSI1P3uybQb74ewZbfoOYBNnfxvKoCgiQAasRb9WXNyND5gSYvtScHA-2BL= X2tf6rJW7FcY-2FPqCfu7mHc7a-2B-2BUpMhAziCidQmWhOTwc0SMf0wWahsudfv3D3AHCr-2Bo= E-3D . Investor Relations Antje Witte, Investor Relations, UCB T +32 2 559 94 14, antje.witte@ucb.com Isabelle Ghellynck, Investor Relations, UCB T +32 2 559 95 88, isabelle.ghellynck@ucb.com About UCB UCB, Brussels, Belgium (www.ucb.com (https://u7061146.ct.sendgrid.net/wf/cl= ick?upn=3D84Em28S1K9SvtzcUtu04EmJ6qK6m5fEduQTondOjhxU-3D_-2B-2Ft0TnE1oEbVIW= S8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElH= Q9EZfLoWbvi8z1TsACjrdOlflPThE-2FfjKrO2oE5hgz3F99bFs6ymkJAL5hjKbtWLrkB-2BYzN= X0AOedNP42fCwgKj2KeSrj-2FfHChuHRcYFO2ggA95Hs-2Bogz6Q3lXPwYSoerCVVu9-2Fh7ocG= C9ImCAOhCfmnKI21eJxaym9nvGbxlSv6qdNqENKhnhyT02lUGrn03YT7zt1ywlToVoZJrSwOjib= f-2B2sDBFZQJ9fig4SBJnCsn5bthDNG7WaaO5huSzGSice2qx8SeSdQIHkE-2Bo-3D ) is a g= lobal biopharmaceutical company focused on the discovery and development of= innovative medicines and solutions to transform the lives of people living= with severe diseases of the immune system or of the central nervous system= . With 7 500 people in approximately 40 countries, the company generated re= venue of =E2=82=AC 4.6 billion in 2018. UCB is listed on Euronext Brussels = (symbol: UCB). Follow us on Twitter: @UCB_news GenericFile 190807 - Notification de transparence comm de presse Blackrock (https://u70= 61146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdGSImvH= Q6HnxeeiysVZrCZyCvoCjypIVyRo7x24r9zgmfNi7f8eBc1Y-2F3Jo1atWJXbaCsfBOk75ioc-3= D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd= 9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsACjrdOlflPThE-2FfjKrO2oE5hgz3F99bFs6ymk= JAL5hjKbtWLrkB-2BYzNX0AOedNP42fCwgKj2KeSrj-2FfHChuHRcYFO2ggA95Hs-2Bogz6Q3lX= PwYlGrn74CA2ni6E40oXSs2tAVkfzKRIE2VrfCmf35niHmkXUbsY20yjWY3GK-2B-2FdcdoMeq0= uW0SBlUo8rPkiBl7mtNM1FkADngeI9HdX9NA2MsVLRnPB6-2FGmRUEwaBep2fS-2F-2FbVn7cpo= rpsymQuyN7Iw-3D GenericFile 190807- Transparantieverklaring persbericht BlackRock (https://u7061146.ct.= sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdGSImvHQ6Hnxeeiy= sVZrCZyCvoCjypIVyRosD7tnlT-2Bfu1W2746wbbz-2BExAM0bvq-2FBMqbi61zQyrFg-3D_-2B= -2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7r= BLYSOuAKeTefElHQ9EZfLoWbvi8z1TsACjrdOlflPThE-2FfjKrO2oE5hgz3F99bFs6ymkJAL5h= jKbtWLrkB-2BYzNX0AOedNP42fCwgKj2KeSrj-2FfHChuHRcYFO2ggA95Hs-2Bogz6Q3lXPwfD6= THajQAVQ60WMN5SCFBwMNJkzwRgBAdOCBuY-2FEUEiAxkVx-2BRSY4T5XWwnyfIAxMmUaDVMBU5= C1-2BT5GNbue8iC-2FuSmpKUdQlraLvkIl9m33ZDN0EtCfCwysOfLyKnCk-2BDdNtj4t3iGvOz7= NKUJ1RQ-3D=0D =0D ______________________=0D If you would rather not receive future communications from UCB SA, please g= o to https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQ= Bz2p53T0v-2BoEIvbo6vDi8C-2BOyFzyb6obo-2BzKSgNKq4mrcihVlfgSqlqm97zB-2FvNch5-= 2BSbmgMo4yrX46hjnekCN6PvikuZxo2OdNn-2FR6wxU4TvSx7IIHzJzJJH3DtoqnU-2FDS4rn3j= s2o8DYZpfyMJZUc-3D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQq= ZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsACjrdOlflPThE-2FfjKrO2= oE5hgz3F99bFs6ymkJAL5hjKbtWLrkB-2BYzNX0AOedNP42fCwgKj2KeSrj-2FfHChuHRcYFO2g= gA95Hs-2Bogz6Q3lXPwU3Cq61aUPbbVolFkONxN-2BBQ3R6cKmFvDbEDvnXVSGZ3Ty7az-2FXcR= x3qYZdoOws4HufNKnqWuflrOeYrkXw3QMhmK4QjFCrKvD6EIIaYT-2BPzfL7asOxUFPViBLhn3d= bmk-2FIQ-2F-2BFuz9Tp3vPtmvQgdyc-3D=0D UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=

UCB's latest news

25/04/2024 18:00

UCB (EBR:UCB) UCB Media Room - Transparency Notifications

Transparency directive : regulatory news

UCB's latest news

Other stories